Wordt geladen...
Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
The soluble urokinase-type plasminogen activator receptor (suPAR) and the urokinase-type plasminogen activator receptor (uPAR) have been proposed as useful biomarkers of tumor progression. Recently, suPAR was associated with chemoresistance in lung cancer. However, its clinical significance in leuke...
Bewaard in:
| Gepubliceerd in: | Oncol Lett |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5494859/ https://ncbi.nlm.nih.gov/pubmed/28693180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6150 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|